Drawing for AZURRX

USPTO serial 79164320

AZURRX

Reviewed by CopyMark Law Group

Reg. 4966792Status 404
Filing date
Status date
Registration date
May 31, 2016
Examiner
GUSTASON, ANNE C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AZURRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce S. Londa

Bruce S. Londa Norris McLaughlin P.A.7 Times SquareNew York, NY 10036-6524UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical products, namely, recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditionsSECTION 71 - CANCELLED—
005Pharmaceutical and veterinary products for the treatment of gasteroenterology/gasterohepatology diseases and infectious diseasesSECTION 71 - CANCELLED—
009Scientific, optical, weighing, measuring apparatus and instruments, namely, electrical equipment for the genetic modification of cells for research purposes; laboratory devices for detecting genetic sequences, laboratory instruments for performing biotechnological manufacturing of biologic proteins, bioreactors, laboratory apparatus for protein purification; calculating machines, data processing apparatus, computers; Computer software in the nature of databases and analytical program applications in the field of research and clinical trials in the field of hepato-gastroenterology and infectious diseases, and pharmaceuticals for the treatment thereofSECTION 71 - CANCELLED—
042Scientific and technological services, namely, research and design in the field of hepato-gastroenterology and infectious diseases, and pharmaceuticals for the treatment thereof; Industrial research in the field of hepato-gastroenterology and infectious diseases, and pharmaceuticals for the treatment thereof; biological analysis services; pharmaceutical research services; design and development of computers and software for use in support of research in the field of hepato-gastroenterology and infectious diseases, and pharmaceuticals for the treatment thereofSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 3, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 3, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 2, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 7, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 7, 2023INPCINVALIDATION PROCESSED—
Aug 16, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 16, 2022C71TCANCELLED SECTION 71—
May 31, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 31, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 31, 2016FIMPFINAL DISPOSITION PROCESSED—
Aug 31, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 31, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 15, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2016GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 9, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 2, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 12, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 6, 2016ALIEASSIGNED TO LIE—
Dec 16, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 11, 2015RFNTREFUSAL PROCESSED BY IB—
Jun 19, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 19, 2015RFRRREFUSAL PROCESSED BY MPU—
Jun 18, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 17, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2015DOCKASSIGNED TO EXAMINER—
May 6, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
May 2, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance